![]() |
17th International AIDS ConferenceMexico City, Mexico - August 13 - 18, 2008 |
VIROLOGICAL SUPPRESSION IN CHILDREN RECEIVING ART IN AN URBAN SOUTH AFRICAN SETTING
Int Conf AIDS. 2008 Aug 13-18;17 Abstract No. MoAb0104
N. Waja, A. Jordan, V. Kgakgadi
, A. Coovadia, K. Technau
Coronation Women and Children Hospital, Empilweni HIV Clinic, Johannesburg, South Africa
AIM: To report on viral load suppression in HIV-1 infected children receiving triple anti-retroviral therapy (ART) at Coronation Women and Children Hospital (CWCH) in South Africa regarding age at initiation of ART.
BACKGROUND: Many challenges have been identified since the public provision of ART in April 2004 in South Africa. Literature indicates high rates of rapid progression in Africa require early ART initiation. Data on how age at initiation of ART affects suppression is needed to identify intervention strategies, ensuring the success of ART.
METHODS: All HIV-1 infected children on ART with 3, 6 and 18 month viral load results, attending CWCH paediatric HIV clinic, were reveiwed. Results were correlated with age at initiation of ART, which was grouped into 0-18 months, 19-60 months and more than 60 months. A viral load of less than 25 copies/ml was considered “fully suppressed”.
RESULTS: Of 1128 children who started ART, 418 had a viral load result at 3 months, 411 at 6 months and 266 at 18 months post-initiation. 261 children had a three or six month and an 18 month result. The suppression rate at 3 and 6 months was significantly lower (p=0.000001 and 0.02 respectively) in children started on ART before age 18 months. Without age stratification children not suppressed by 3 or 6 months had a significant risk of suppression failure by 18 months (p=0.001).
CONCLUSIONS: Children starting ART at a younger age were less likely to be suppressed by three and six months post-initiation. Children not suppressed by three or six months post-initiation were less likely to be suppressed by 18 months post-initiation.Further studies are required regarding the relationship between age at initiation of ART and time to virological suppression to elucidate the underlying causes that make the younger age group more vulnerable to suppression failure.
Download PDF of this abstract.
2008-08-13
MoAb0104
Copyright © 2008 - International AIDS Society (IAS). All information and content relating to the abstracts from the 16th International AIDS Conference, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.
AEGiS is a 501c(3) not-for-profit organization made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, GlaxoSmithKline, the National Library of Medicine, Roche / Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.